Defining distinct features of anti-MOG antibody associated central nervous system demyelination.

about

Defining distinct features of anti-MOG antibody associated central nervous system demyelination.

Item

http://www.wikidata.org/entity/Q52603606

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Defining distinct features of ...... nervous system demyelination.

@en

Defining distinct features of ...... nervous system demyelination.

@nl

type

Item

label

Defining distinct features of ...... nervous system demyelination.

@en

Defining distinct features of ...... nervous system demyelination.

@nl

prefLabel

Defining distinct features of ...... nervous system demyelination.

@en

Defining distinct features of ...... nervous system demyelination.

@nl

P1476

Defining distinct features of ...... nervous system demyelination.

@en

P2093

Imke Metz

http://www.w3.org/2001/XMLSchema#string

Martin S Weber

http://www.w3.org/2001/XMLSchema#string

Tobias Derfuss

http://www.w3.org/2001/XMLSchema#string

Wolfgang Brück

http://www.w3.org/2001/XMLSchema#string

P2860

Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients

Anti-MOG antibodies are present in a subgroup of patients with a neuromyelitis optica phenotype

The history of neuromyelitis optica

International consensus diagnostic criteria for neuromyelitis optica spectrum disorders

Physiological roles of aquaporin-4 in brain

A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules

Structural and functional features of central nervous system lymphatic vessels.

Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event

Anti-MOG antibodies plead against MS diagnosis in an Acquired Demyelinating Syndromes cohort

Histopathology and clinical course of MOG-antibody-associated encephalomyelitis

P304

1756286418762083

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1756286418762083

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-03-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29623106

http://www.w3.org/2001/XMLSchema#string

P932

5881972

http://www.w3.org/2001/XMLSchema#string